Evidence map›Paper›PMID 30589847›Full record

ArticlePLoS neglected tropical diseases2018

Health, financial, and education gains of investing in preventive chemotherapy for schistosomiasis, soil-transmitted helminthiases, and lymphatic filariasis in Madagascar: A modeling study.

Jan-Walter De Neve, Rija L Andriantavison, Kevin Croke, Johannes Krisam, Voahirana H Rajoela, Rary A Rakotoarivony, Valérie Rambeloson, Linda Schultz, Jumana Qamruddin, Stéphane Verguet

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 5 pooled it
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 5 syntheses or guidelines pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Jan-Walter De NeveInstitute of Global Health, Medical Faculty and University Hospital, Heidelberg University, Heidelberg, Germany.ORCID 0000-0003-0090-8249
Rija L AndriantavisonWorld Bank Madagascar Country Office, Antananarivo, Madagascar.
Kevin CrokeDepartment of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston MA, United States of America.
Johannes KrisamInstitute of Medical Biometry and Informatics, Heidelberg University, Heidelberg, Germany.ORCID 0000-0003-4092-7874
Voahirana H RajoelaWorld Bank Madagascar Country Office, Antananarivo, Madagascar.
Rary A RakotoarivonyWorld Bank Madagascar Country Office, Antananarivo, Madagascar.
Valérie RambelosonWorld Bank Madagascar Country Office, Antananarivo, Madagascar.
Linda SchultzWorld Bank, Washington DC NW, Washington, DC, United States of America.
Jumana QamruddinWorld Bank, Washington DC NW, Washington, DC, United States of America.
Stéphane VerguetDepartment of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston MA, United States of America.
World Bank · USHeidelberg University · DEHarvard Global Health Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNeglected tropical diseases (NTDs) account for a large disease burden in sub-Saharan Africa. While the general cost-effectiveness of NTD interventions to improve health outcomes has been assessed, few studies have also accounted for the financial and education gains of investing in NTD control.

methodsWe built on extended cost-effectiveness analysis (ECEA) methods to assess the health gains (e.g. infections, disability-adjusted life years or DALYs averted), household financial gains (out-of-pocket expenditures averted), and education gains (cases of school absenteeism averted) for five NTD interventions that the government of Madagascar aims to roll out nationally. The five NTDs considered were schistosomiasis, lymphatic filariasis, and three soil-transmitted helminthiases (Ascaris lumbricoides, Trichuris trichiura, and hookworm infections).

resultsThe estimated incremental cost-effectiveness for the roll-out of preventive chemotherapy for all NTDs jointly was USD125 per DALY averted (95% uncertainty range: 65-231), and its benefit-cost ratio could vary between 5 and 31. Our analysis estimated that, per dollar spent, schistosomiasis preventive chemotherapy, in particular, could avert a large number of infections (176,000 infections averted per $100,000 spent), DALYs (2,000 averted per $100,000 spent), and cases of school absenteeism (27,000 school years gained per $100,000 spent).

conclusionThis analysis incorporates financial and education gains into the economic evaluation of health interventions, and therefore provides information about the efficiency of attainment of three Sustainable Development Goals (SDGs). Our findings reveal how the national scale-up of NTD control in Madagascar can help address health (SDG3), economic (SDG1), and education (SDG4) goals. This study further highlights the potentially large societal benefits of investing in NTD control in low-resource settings.

Indexed as

AdolescentAnthelminticsChildChild, PreschoolCost-Benefit AnalysisElephantiasis, FilarialFemaleHealth EducationHelminthiasisHumansMadagascarMaleSchistosomiasisSoilTropical MedicineAnthelminticsSoil

Identifiers

PMID30589847
PMCPMC6307713
OpenAlexW2907656327

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.